Explore Business Standard
Don’t miss the latest developments in business and finance.
A month after opening its first American outlet, Tanishq, India's leading jewelry retail brand from the house of Tata, feels that the United States offers huge opportunities for not only itself but also for other Indian retail brands as well. This is mainly attributed to the large presence of Indian Diaspora in the country, who are among the highest per-capita income, but also because of the interest in India, its culture and products among the Americans. "The opportunity is huge. Just from an Indian diaspora perspective, a South Asian diaspora perspective, and then even beyond that, the opportunity is huge. If you just focus on, let's say the Indian diaspora part, the people here, and that is an important part of our decision to enter here, said Amrit Pal Singh, business head- North America, Titan Company that runs the chain of jewelry stores in both India and overseas under the brand of Tanishq. Before entering the US market, Tanishq spent two years in studying the North American
Wall Street is heading lower ahead of Monday's opening bell amid widespread protests in China calling for Xi Jinping to step down and an end to one-party rule. Futures for the Dow Jones industrials fell 0.5 per cent and the S and P slipped 0.7 per cent. Crude prices neared a low point for the year partially due to unrest in China, and have fallen for three consecutive weeks. Crude prices are now negative for 2022 and, after soaring above USD 120 in June, a barrel of benchmark US crude can now be had for less than USD 74 per barrel. The upheaval in China is the greatest show of public dissent against the ruling Communist Party in decades. Protestors are railing against policies aimed at eradicating the coronavirus by isolating every case, a policy that may have contributed to the death toll in an apartment fire in Urumqi in the northwestern Xinjiang region. For investors, when it comes to China, trying to predict with any degree the reopening certainty that has no certainty, basis,
Aurobindo Pharma units are recalling different products in the US market for manufacturing lapses, as per the US health regulator. According to the latest Enforcement Report by the US Food and Drug Administration (USFDA), New Jersey-based Aurobindo Pharma USA Inc is recalling 9,504 bottles of Quinapril and Hydrochlorothiazide tablets. The affected lot of the medication, which is used to treat high blood pressure, has been manufactured in India and marketed in the US market by Aurobindo Pharma USA, Inc. As per the USFDA, the company is recalling the affected lot due to "Current good manufacturing practices CGMP deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit." Nitrosamines are a group of compounds which can damage DNA in the long term. The company, a unit of Hyderabad-based Aurobindo Pharma, initiated the Class II voluntary recall on October 5 this year. In a separate statement, USFDA said AuroMedics Pharma LLC, a unit of Aurobindo Phar